Healthcare provider profile · identity verified

Roy Kadair, MD

Internal Medicine · BATON ROUGE, LA · NPI 1033136965

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Levothyroxine Sodium	Levothyroxine Sodium	833	191
Losartan Potassium	Losartan Potassium	611	156
Amlodipine Besylate	Amlodipine Besylate	549	138
Atorvastatin Calcium	Atorvastatin Calcium	505	150
Metformin Hcl	Metformin Hcl	406	104
Rosuvastatin Calcium	Rosuvastatin Calcium	394	114
Simvastatin	Simvastatin	366	87
Lorazepam	Lorazepam	325	60
Trazodone Hcl	Trazodone Hcl	261	54
Pantoprazole Sodium	Pantoprazole Sodium	243	70
Gabapentin	Gabapentin	237	53
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	233	63
Metoprolol Succinate	Metoprolol Succinate	231	51
Hydrochlorothiazide	Hydrochlorothiazide	225	59
Alprazolam	Alprazolam	223	35
Escitalopram Oxalate	Escitalopram Oxalate	208	46
Metformin Hcl Er	Metformin Hcl	205	52
Spironolactone	Spironolactone	203	54
Omeprazole	Omeprazole	182	53
Allopurinol	Allopurinol	177	42
Pravastatin Sodium	Pravastatin Sodium	174	46
Potassium Chloride	Potassium Chloride	165	49
Citalopram Hbr	Citalopram Hydrobromide	164	33
Lisinopril	Lisinopril	160	44
Atenolol	Atenolol	137	32
Tamsulosin Hcl	Tamsulosin Hcl	129	33
Glimepiride	Glimepiride	123	30
Furosemide	Furosemide	118	38
Clonazepam	Clonazepam	114	20
Bupropion Xl	Bupropion Hcl	113	25
Ezetimibe	Ezetimibe	111	27
Synthroid	Levothyroxine Sodium	104	24
Terazosin Hcl	Terazosin Hcl	104	22
Meloxicam	Meloxicam	99	28
Felodipine Er	Felodipine	96	23
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	94	30
Finasteride	Finasteride	93	26
Eliquis	Apixaban	84	17
Irbesartan	Irbesartan	82	20
Montelukast Sodium	Montelukast Sodium	80	21
Venlafaxine Hcl Er	Venlafaxine Hcl	77	12
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	76	15
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	74	17
Zolpidem Tartrate	Zolpidem Tartrate	72	20
Fluoxetine Hcl	Fluoxetine Hcl	71	13
Clopidogrel	Clopidogrel Bisulfate	70	21
Doxazosin Mesylate	Doxazosin Mesylate	63	13
Albuterol Sulfate Hfa	Albuterol Sulfate	58	21
Donepezil Hcl	Donepezil Hcl	55	14
Esomeprazole Magnesium	Esomeprazole Magnesium	55	14
Jardiance	Empagliflozin	55	18
Diazepam	Diazepam	53	suppressed
Ozempic	Semaglutide	48	suppressed
Chlorthalidone	Chlorthalidone	47	13
Fenofibrate	Fenofibrate	47	12
Risedronate Sodium	Risedronate Sodium	45	17
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	44	suppressed
Fluticasone Propionate	Fluticasone Propionate	43	19
Duloxetine Hcl	Duloxetine Hcl	42	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	41	suppressed
Irbesartan-Hydrochlorothiazide	Irbesartan/Hydrochlorothiazide	41	suppressed
Metoprolol Tartrate	Metoprolol Tartrate	38	13
Buspirone Hcl	Buspirone Hcl	37	suppressed
Carvedilol	Carvedilol	36	suppressed
Glipizide	Glipizide	36	suppressed
Glipizide Er	Glipizide	36	suppressed
Hydralazine Hcl	Hydralazine Hcl	36	suppressed
Glyburide-Metformin Hcl	Glyburide/Metformin Hcl	35	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	35	suppressed
Verapamil Er	Verapamil Hcl	34	suppressed
Telmisartan	Telmisartan	33	suppressed
Tizanidine Hcl	Tizanidine Hcl	33	18
Quetiapine Fumarate	Quetiapine Fumarate	32	suppressed
Sertraline Hcl	Sertraline Hcl	32	suppressed
Valacyclovir	Valacyclovir Hcl	32	16
Xarelto	Rivaroxaban	31	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	30	suppressed
Celecoxib	Celecoxib	30	suppressed
Benazepril Hcl	Benazepril Hcl	28	suppressed
Indapamide	Indapamide	28	suppressed
Raloxifene Hcl	Raloxifene Hcl	28	suppressed
Tramadol Hcl	Tramadol Hcl	28	suppressed
Temazepam	Temazepam	27	suppressed
Januvia	Sitagliptin Phosphate	24	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	24	suppressed
Toujeo Solostar	Insulin Glargine,hum.Rec.Anlog	24	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	23	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	23	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	23	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	22	suppressed
Olmesartan-Hydrochlorothiazide	Olmesartan/Hydrochlorothiazide	22	suppressed
Mirtazapine	Mirtazapine	21	suppressed
Valsartan	Valsartan	21	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	20	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	19	15
Nifedipine Er	Nifedipine	19	suppressed
Diclofenac Sodium	Diclofenac Sodium	18	suppressed
Pregabalin	Pregabalin	18	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	18	18
Warfarin Sodium	Warfarin Sodium	18	suppressed
Nebivolol Hcl	Nebivolol Hcl	17	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	17	16
Topiramate	Topiramate	17	suppressed
Fludrocortisone Acetate	Fludrocortisone Acetate	16	suppressed
Lansoprazole	Lansoprazole	16	suppressed
Alendronate Sodium	Alendronate Sodium	15	suppressed
Dropsafe Prep Pads	Alcohol Antiseptic Pads	15	suppressed
Lovastatin	Lovastatin	15	suppressed
Clonidine Hcl	Clonidine Hcl	14	suppressed
Estradiol	Estradiol	14	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	14	suppressed
Sucralfate	Sucralfate	14	suppressed
Livalo	Pitavastatin Calcium	13	suppressed
Methylprednisolone	Methylprednisolone	13	11
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	13	suppressed
Azelastine Hcl	Azelastine Hcl	12	suppressed
Cevimeline Hcl	Cevimeline Hcl	12	suppressed
Diltiazem 24hr Er	Diltiazem Hcl	12	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	12	suppressed
Ipratropium Bromide	Ipratropium Bromide	12	suppressed
Paroxetine Hcl	Paroxetine Hcl	12	suppressed
Pitavastatin Calcium	Pitavastatin Calcium	12	suppressed
Ramipril	Ramipril	12	suppressed
Rivastigmine	Rivastigmine	12	suppressed
Telmisartan-Hydrochlorothiazid	Telmisartan/Hydrochlorothiazid	12	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	12	suppressed
Chlordiazepoxide-Clidinium	Chlordiazepoxide/Clidinium Br	11	suppressed
Clorazepate Dipotassium	Clorazepate Dipotassium	11	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	11	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	11	suppressed
Zaleplon	Zaleplon	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error